Literature DB >> 12612601

Modification with SUMO. A role in transcriptional regulation.

Alexis Verger1, José Perdomo, Merlin Crossley.   

Abstract

Small ubiquitin-related modifier (SUMO) is a protein moiety that is ligated to lysine residues in a variety of target proteins. The addition of SUMO can modulate the ability of proteins to interact with their partners, alter their patterns of subcellular localization and control their stability. It is clear that SUMO influences many different biological processes, but recent data suggest that it is particularly important in the regulation of transcription. Indeed, several transcription factors, such as Sp3, c-Jun, c-Myb and various nuclear receptors, have recently been shown to be subject to sumoylation and, although this modification can have a positive influence, a growing body of evidence highlights its role in the negative regulation of transcription. This review summarizes recent experiments focusing on sumoylation and transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612601      PMCID: PMC1315836          DOI: 10.1038/sj.embor.embor738

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  47 in total

1.  Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription.

Authors:  H Poukka; P Aarnisalo; U Karvonen; J J Palvimo; O A Jänne
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

2.  Transcription factor Sp3 is regulated by acetylation.

Authors:  H Braun; R Koop; A Ertmer; S Nacht; G Suske
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

3.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.

Authors:  S Sachdev; L Bruhn; H Sieber; A Pichler; F Melchior; R Grosschedl
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

4.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.

Authors:  Darja Schmidt; Stefan Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

5.  Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover.

Authors:  Ulrike Hardeland; Roland Steinacher; Josef Jiricny; Primo Schär
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

6.  The nucleoporin RanBP2 has SUMO1 E3 ligase activity.

Authors:  Andrea Pichler; Andreas Gast; Jacob S Seeler; Anne Dejean; Frauke Melchior
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

7.  Activation of p53 by protein inhibitor of activated Stat1 (PIAS1).

Authors:  Tamar Megidish; Juliana H Xu; C Wilson Xu
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

8.  Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification.

Authors:  Y Hong; R Rogers; M J Matunis; C N Mayhew; M L Goodson; O K Park-Sarge; K D Sarge; M Goodson
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

Review 9.  Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport.

Authors:  Andrea Pichler; Frauke Melchior
Journal:  Traffic       Date:  2002-06       Impact factor: 6.215

10.  Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity.

Authors:  Juraj Bies; Ján Markus; Linda Wolff
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

View more
  171 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

3.  SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.

Authors:  Gergana Dobreva; Julia Dambacher; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

4.  Histone modifications: Now summoning sumoylation.

Authors:  Dafna Nathan; David E Sterner; Shelley L Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

5.  Modification of the erythroid transcription factor GATA-1 by SUMO-1.

Authors:  Licio Collavin; Monica Gostissa; Fabio Avolio; Paola Secco; Antonella Ronchi; Claudio Santoro; Giannino Del Sal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

6.  Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis.

Authors:  Tianwei Li; Evgenij Evdokimov; Rong-Fong Shen; Chien-Chung Chao; Ephrem Tekle; Tao Wang; Earl R Stadtman; David C H Yang; P Boon Chock
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

7.  SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication.

Authors:  Michael Nevels; Wolfram Brune; Thomas Shenk
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Role of the fission yeast SUMO E3 ligase Pli1p in centromere and telomere maintenance.

Authors:  Blerta Xhemalce; Jacob-S Seeler; Geneviève Thon; Anne Dejean; Benoît Arcangioli
Journal:  EMBO J       Date:  2004-09-09       Impact factor: 11.598

9.  Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.

Authors:  Serge Grégoire; Xiang-Jiao Yang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 10.  Molecular mechanisms driving transcriptional stress responses.

Authors:  Anniina Vihervaara; Fabiana M Duarte; John T Lis
Journal:  Nat Rev Genet       Date:  2018-06       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.